Learn how the two forms of semaglutide compare in treating type 2 diabetes and supporting weight loss, plus their dosing ...

The great outdoors isn’t the best spot to be unprepared for diabetes symptoms. Here’s what you’ll want to pack and plan for.

Mochi Health has a Better Business Bureau (BBB) customer review rating of 1.32 out of 5 stars. Most complaints were related ...

TEARING open her special delivery padded envelope, Paige Osprey carefully removed the small glass vial filled with 10ml of clear fluid.  Despite it being clearly marked for “research purposes ...

Good morning, ladies and gentlemen, and welcome to the Altimmune First Quarter 2026 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I'll now ...

GoodRx reports that Foundayo, a new oral weight-loss pill, is FDA-approved for obesity treatment, offering an alternative to ...

Greetings, and welcome to the Amphastar Pharmaceuticals First Quarter Earnings Call. [Operator Instructions] Please note that certain statements made during this call regarding matters that are not ...

New treatment option: FDA approved Zepbound in 2024 as the first drug specifically for obstructive sleep apnea in adults with obesity. Study-backed benefits: A JAMA study found GLP-1 users were less ...

Zepbound is a prescription drug used to help with weight loss and sleep apnea in certain adults. The starting dosage for weight loss and sleep apnea is 2.5 mg injected once weekly for 4 weeks. Your ...

Detailed price information for Xeris Pharmaceuticals Inc (XERS-Q) from The Globe and Mail including charting and trades.

Thursday, May 7, 2026 at 8 a.m. ET. CALL PARTICIPANTS. President and Chief Executive Officer — Charles D. Goodwin; Chief Financial Officer — Matthew Hill; TAKEAWAYS. Tot ...